Use of Theraflex-TMJ topical cream for the treatment of temporomandibular joint and muscle pain

Cranio - Journal of Craniomandibular and Sleep Practice

Volumn 22, Issue 2, 2004, Pages 137-144

  Lobo Lobo, Silvia ^a,b,c,d   Mehta, Noshir ^a,c,e,f   Forgione, Albert G ^a,e,g   Melis, Marcello ^c,h,i   Al Badawi, Emad ^a,e,j,k   Ceneviz, Caroline ^a,n   Zawawi, Khalid H ^e,g,j,l,m  

^a TUFTS UNIVERSITY SCHOOL OF DENTAL MEDICINE   (United States)

^b Latinamerican University of Science and Technology   (Costa Rica)

^c TUFTS UNIVERSITY   (United States)

^d Craniofacial Pain Center   (United States)

^e American Board of Orofacial Pain   (United States)

^f International College of Dentists

^g BOSTON UNIVERSITY   (United States)

^h UNIVERSITY OF CAGLIARI   (Italy)

ⁱ Dental School

^j KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^k KING FAHAD GENERAL HOSPITAL   (Saudi Arabia)

^l UNIVERSITY OF THE PUNJAB   (Pakistan)

^m Gelb Center

ⁿ UNIARARAS   (Brazil)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; PLACEBO; TOPICAL AGENT;

ADULT; ARTICLE; BURNING SENSATION; CALCULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDICATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MASSETER MUSCLE; MYALGIA; MYOFASCIAL PAIN; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SKIN IRRITATION; TEMPOROMANDIBULAR JOINT;

EID: 2342483636     PISSN: 08869634     EISSN: None     Source Type: Journal    
DOI: 10.1179/crn.2004.018     Document Type: Article

References (34)

1. Simons DG: Muscle pain syndromes - Part I. Am J Physical Med 1975; 54:289-311.
2. Dolwick MF, Katzberg RW, Helms CA: Internal derangements of the temporomandibular joint: fact or fiction? J Prosthet Dent 1983; 49:415-418.
3. Dworkin SF, LeResche R: Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord Facial Oral Pain 1992; 6:301-355.
4. Okeson JP: Differential diagnosis and management considerations of temporomandibular disorders. In: Okeson JP, ed. Orofacial pain, guidelines for assessment, diagnosis, and management. Chicago:Quintessence, 1993; 113-184.
5. Brooke RI, Stenn PG, Mothersill KJ: The diagnosis and conservative treatment of myofascial pain dysfunction syndrome. Oral Surg Oral Med Oral Pathol 1977; 44(6):844-852.
6. Dahlstrom, L, Widmark G, Carlsson SG: Cognitive-behavioral profiles among different categories of orofacial pain patients: diagnostic and treatment implications. Eur J Oral Sci 1997; 105(5):377-383.
7. Gavish A, Winocur E, Ventura YS, Halachi M, Gazit E: Effect of stabilization splint therapy on pain during chewing in patients suffering from myofascial pain. J Oral Rehabil 2002; 29(12):1181-1186.
8. Komiyama O, Kawara M, Arai M, Asano T, Kobayashi K: Posture correction as part of behavioural therapy in treatment of myofascial pain with limited 3 opening. J Oral Rehabil 1999; 26(5):428-435.
9. Reston JT, Turkelson CM: Meta-analysis of surgical treatments for temporomandibular articular disorders. J Oral Maxillofac Surg 2003; 61(1):3-10.
10. Roark AL, Glaros AG, et al.: Effects of interocclusal appliances on EMG activity during parafunctional tooth contact. J Oral Rehabil 2003; 30(6):573-577.
11. Rainsford KD: Copper and zinc in inflammatory and degenerative diseases. Boston, MA: Kluwer Academic Publishers, 1998.
12. Sorenson JR: Copper complexes offer a physiological approach to treatment of chronic diseases. Prog Med Chem 1989; 26:437-568.
13. Pirot F, Millet J, Kalia YN: In vitro study of percutaneous absorption, cutaneous bioavility, and bioequivalence of zinc and copper from five topical formulations. Skin Pharmacology 1996; 9:259-269.
14. Walker WR, Keats DM: An investigaton of the therapeutic value of the "copper bracelet," dermal assimilation of copper in arthritic/rheumatoid conditions. Agents and Actions 1976; 6:454-459.
15. Milanino R, Marella M, Crivellente F, Benoni G, Cuzzolin L: Nutritional supplementation with copper in the rat. I. Effects on adjuvant arthritis development and on some in vivo- and ex vivo-markers of blood neutrophils. Inflamm Res 2000; 49:214-223.
16. Milanino R, Marella M, Moretti U, Concari E, Velo GP: Copper and zinc status in rats with acute inflammation: focus on the inflamed area. Agents and Actions 1988; 24:356-364.
17. Conforti A, Franco L, Menegale G, Milanino R, Piemonte G, Velo GP: Serum copper and ceruloplasmin levels in rheumatoid arthritis and degenerative joint disease and their pharmacological implications. Pharmacol Res Commun 1983; 15:859-867.
18. Milanino R, Conforti A, Franco L, Marella M, Velo G: Copper and inflammation - a possible rationale for the pharmacological manipulation of inflammatory disorders. Agents and Actions 1985; 16:503-513.
19. Milanino R, Frigo A, Bambara LM, Marella M, Moretti U, Pasqualicchio M, Biasi D, Gasperini R, Mainenti L, Velo GP: Copper and zinc status in rheumatoid arthritis: studies of plasma, erythrocytes, and urine, and their relationship to disease activity markers and pharmacological treatment. Clin Exp Rheumatol 1993; 11:271-281.
20. Sukalski KA, LaBerge TP, Johnson WT: In vivo oxidative modification of erythrocyte membrane proteins in copper deficiency. Free Radic Biol Med 1997; 22:835-842.
21. Berthon G: Is copper pro- or anti-inflammatory? A reconciling view and a novel approach for the use of copper in the control of inflammation. Agents and Actions 1993; 39:210-217.
22. Louro MC, Cocho J, Mera A: Immunochemical and enzymatic study of ceruloplasmin in rheumatoid arthritis. Journal of Trace Elements in Medicine and Biology 2000; 14:174-178.
23. Waggoner DJ: The role of copper in neurodegenerative disease. Neurobiology of Disease 1999; 6:221-230.
24. Failla M, Johnson MA, Prohaska J: Copper. In: Russell BBaR, ed. Present knowledge in nutrition. Washington DC: International Life Sciences Institute, 2001; 373-383.
25. Beveridge RJ: Topically applied copper preparations for anti-inflammatory therapy. In: Rainsford KD, ed. Copper and zinc in inflammatory and degenerative diseases. Boston, MA: Kluwer Academic Publishers, 1998; 130-145.
26. Dibley M: Zinc. In: Russell BBaR, ed. Present knowledge in nutrition. Washington DC: International Life Sciences Institute, 2001:329-341.
27. Prasad AS: Discovery and importance of zinc in human nutrition. Fed Proc 1984; 43:2829-2834.
28. Salgueiro MJ: Zinc, status and immune system relationship. Biological Trace Elements Research 2000; 76:193-205.
29. Fernandez-Madrid F: Zinc and copper in the treatment of rheumatic diseases. In: Rainsford KD, ed. Copper and zinc in inflammatory and degenerative diseases. Boston: Kluwer Academic Publishers, 1998; 125-130.
30. LaValle JB, Krinsky D, Hawkins E: Natural therapeutics pocket guide. Ohio: Lexi-Comp, 2000.
31. Blumenthal M: The complete German Comission E monographs: Therapeutic guide to herbal medicine/developed by a special expert committee of the German Federal Institute for drugs and medical devices. Boston, MA: Integrative Medicine Communications, 1998.
32. Choiniere M, Melzak R, Girard N, Rondeau J, Paquin MJ: Comparisons between patients' and nurses' assessment of pain and medication efficacy in severe burn injuries Pain 1990; 40:143-152.
33. Anonymous: OTC update: heat rubs and topical analgesics for muscular pain. Community Nurse 1997; 3:62.
34. Reisner L: Musculoskeletal injuries and disorders. In: Berardi R, DeSimone II E, Newton G, Oszko M, Popovich N, Rollins C, Shimp L, Tietze K, eds.: Handbook of nonprescription drugs. Washington DC:American Pharmaceutical Association, 2000; 98.